Since November 2020 Fujirebio Europe and CENTOGENE have partnered to leverage LUMIPULSE® G technology for large-scale COVID-19 antigen testing in various German airports, supported by CENTOGENE test centers.
In these airports, sample collection is performed by dedicated CENTOGENE teams, the analysis is performed at CENTOGENE test laboratories using the Lumipulse G SARS-CoV-2 antigen test running on LUMIPULSE G1200 instruments, delivering fast and high-quality results.
In this scenario LUMIPULSE technology is an integrated part of the sophisticated automated CENTOGENE workflow that ensures fast and direct delivery of antigen testing results to travelers on their smartphones or digital devices.
Travelers receive their test results within just one hour after the initial sample collection.
See more about how it works in the video below or read more here about how Fujirebio plays an important role as a healthcare partner, offering various testing solutions that are used across the world today to support fast and trustworthy diagnosis.
Lumipulse G SARS-CoV-2 Ag was the first high-sensitive nucleocapsid protein antigen assay launched on a fully automated chemiluminescent platform.
May 27, 2021
During this webinar Dr. Francesco Bonella (MD - Center for Interstitial & Rare Lung Disease, Department of Pulmonology, Ruhrlandklinik University...
Oct 19, 2020
Several fully automated and CLEIA-based LUMIPULSE G1200 systems from Fujirebio are right now performing fast, high sensitivity SARS CoV-2 antigen...
Aug 26, 2020
Product number 231906 -
Immunochromatographic assay for the detection of SARS-CoV-2 antigen directly from nasopharyngeal swab fluid and is intended for use as an aid in the diagnosis of SARS-CoV-2 infection.
iAMP COVID-19 Detection Kit
Product number 80767, 80762 -
Qualitative nucleic acid detection of SARS-CoV-2 (COVID-19) on naso- or oropharyngeal swabs without pre-treatment.
iAMP COVID-19 SANO Assay
Product number 81104, 80762, 80812 -
Qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal swabs and saliva specimens from individuals with signs and symptoms of infection who are suspected of COVID-19.
Lumipulse® G CEA-N (Carcinoembryonic Antigen)
Product number 292662 -
Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of carcinoembryonic antigen (CEA) in serum or plasma.
Lumipulse® G CYFRA (Cytokeratin Subunit 19 Fragment)
Product number 292945 -
Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of cytokeratin subunit 19 fragment (CYFRA) in serum or plasma.
Lumipulse® G KL-6 (Krebs von den Lungen)
Product number 233207 -
Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of sialylated carbohydrate antigen, KL-6 in serum or plasma.
Lumipulse® G Mesothelin
Product number 294192 -
Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative determination Soluble Mesothelin Related Peptides (SMRP) in human serum or plasma.
Lumipulse® G ProGRP (Pro-Gastrin-Releasing Peptide)
Product number 297858 -
Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of Pro-gastrin-releasing peptide [ProGRP (31-98)] in serum or plasma.
Lumipulse® G SARS-CoV-2 Ag
Product number 260340, 231869 -
For in vitro diagnostic (IVD) use with the Lumipulse G system for detection and quantitative measurement of SARS-CoV-2 nucleocapsid protein antigen in human nasopharyngeal swab or saliva. As a diagnostic tool for the confirmation of a SARS-CoV-2 infection.
Lumipulse® G SARS-CoV-2 S-IgG
Product number 232231 -
Lumipulse G SARS-CoV-2 S-IgG is an assay system, including a set of immunoassay reagents, for the quantitative measurement of IgG-type antibodies SARS-CoV-2 spike protein (SARS-CoV-2 S-IgG) in specimens based on CLEIA technology by a specific two-step immunoassay method on the LUMIPULSE G System.
Lumipulse® G SCC (Squamous Cell Carcinoma)
Product number 298411, 235430 -
Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G instruments for the quantitative measurement of squamous cell carcinoma (SCC) antigen in human serum or plasma samples as an aid in the management of patients with squamous cell carcinoma.